Central Pharma
Central Pharma is a leading pharmaceutical contract service provider specializing in manufacturing, packaging, storage, logistics, regulatory support, serialisation, and technology solutions for the healthcare industry. Established in 2006, the company operates multiple sites globally, offering scalable, high-quality, and compliant services for pharmaceutical, medical device, cell & gene, and healthcare sectors. Central Pharma is committed to innovation, quality, and supporting local communities through education and training, aiming to be an efficient and reliable partner in the healthcare supply chain.
Industries
Nr. of Employees
medium (51-250)
Central Pharma
Bedford, Bedfordshire, United Kingdom, Europe
Products
Custom research-grade AAV vectors
Tailored AAV vector production (including serotype selection and yield optimisation) for gene therapy development, neuroscience and preclinical research.
Scalable multi-layer roller bottle production system
A scalable cell-culture production approach intended to support early-stage R&D through higher-volume preclinical batch production.
Custom research-grade AAV vectors
Tailored AAV vector production (including serotype selection and yield optimisation) for gene therapy development, neuroscience and preclinical research.
Scalable multi-layer roller bottle production system
A scalable cell-culture production approach intended to support early-stage R&D through higher-volume preclinical batch production.
Services
Contract filling and secondary packing using flexible manual and automated lines to support clinical and commercial product supply.
Scalable multi-site temperature-controlled warehousing and time-critical transport solutions with real-time temperature monitoring and inventory reporting for cell & gene therapy and pharmaceutical products.
Regulatory consultancy services including quality management system support, inspection readiness, PAI readiness, QA/QC oversight and QP release support.
Serialisation services for product tracking and regulatory compliance across supply chains.
Integration of AI-driven vision inspection, OEE analytics and IoT sensor data to enable real-time monitoring, quality inspection and automated process optimisation on production lines.
Customisable AAV vector production services for research, preclinical and translational applications, delivered in BSL-2 facilities with scalable production approaches.
Contract filling and secondary packing using flexible manual and automated lines to support clinical and commercial product supply.
Scalable multi-site temperature-controlled warehousing and time-critical transport solutions with real-time temperature monitoring and inventory reporting for cell & gene therapy and pharmaceutical products.
Regulatory consultancy services including quality management system support, inspection readiness, PAI readiness, QA/QC oversight and QP release support.
Serialisation services for product tracking and regulatory compliance across supply chains.
Integration of AI-driven vision inspection, OEE analytics and IoT sensor data to enable real-time monitoring, quality inspection and automated process optimisation on production lines.
Customisable AAV vector production services for research, preclinical and translational applications, delivered in BSL-2 facilities with scalable production approaches.
Expertise Areas
- Contract manufacturing and packaging (pharmaceutical and medical device)
- Cell and gene therapy manufacturing and logistics
- Cold-chain logistics and temperature-controlled storage
- Regulatory compliance and quality systems (GMP/GDP/ISO/MHRA/FDA)
Key Technologies
- AI-powered vision systems for visual inspection
- IoT sensors for environmental and equipment monitoring
- OEE (Overall Equipment Effectiveness) analytics software
- Temperature-controlled cold-chain storage (including LN2)
News & Updates
Central Pharma exhibited at CPhI in Frankfurt from 1-3 November 2022, engaging with industry professionals and showcasing their services.
In February 2021, Central Pharma acquired Biotechnica, UK's largest manufacturer of seaweed extract, expanding into the nutraceutical market.
In March 2023, Central Pharma adopted electric vehicles to support sustainability and reduce emissions.
Central Pharma welcomed Dr. Mark Morton, with 20 years of industry experience, as the new Quality Director.
Guidance on safety practices for employees and their families to ensure well-being outside the workplace.
An article discussing the importance of quality assurance and strategic partnerships in pharma outsourcing.
Central Pharma exhibited at CPhI in Frankfurt from 1-3 November 2022, engaging with industry professionals and showcasing their services.
In February 2021, Central Pharma acquired Biotechnica, UK's largest manufacturer of seaweed extract, expanding into the nutraceutical market.
In March 2023, Central Pharma adopted electric vehicles to support sustainability and reduce emissions.
Central Pharma welcomed Dr. Mark Morton, with 20 years of industry experience, as the new Quality Director.
Guidance on safety practices for employees and their families to ensure well-being outside the workplace.
An article discussing the importance of quality assurance and strategic partnerships in pharma outsourcing.